A Call to Include Severe Combined Immunodeficiency in Newborn Screening Program
Authors:
Open Access
- 21 January 2014
- journal article
- research article
- Published by Rambam Health Corporation in Rambam Maimonides Medical Journal
- Vol. 5 (1) , e0001
Abstract
Quantification of the T cell receptor excision circles (TRECs) has recently emerged as a useful non-invasive clinical and research tool to investigate thymic activity. It allows the identification of T cell production by the thymus. Quantification of TREC copies has recently been implemented as the preferred test to screen neonates with severe combined immunodeficiency (SCID) or significant lymphopenia. Neonatal genetic screening for SCID is highly important in countries with high rates of consanguinous marriages, such as Israel, and can be used for early diagnosis, enabling prompt therapeutic intervention that will save lives and improve the outcome of these patients. TREC measurement is also applicable in clinical settings where T cell immunity is involved, including any T cell immunodeficiencies, HIV infection, the aging process, autoimmune diseases, and immune reconstitution after bone marrow transplantation. Severe combined immunodeficiency, a life-threatening condition, can be detected by neonatal screening.The earlier the detection and the quicker the implementation of appropriate treatment, the greater the likelihood for improved outcome, even cure, for the affected children.TRECs and KRECs quantification are useful screening tests for severe T and B cell immunodeficiency and can be used also to evaluate every medical condition involving T and B cell immunity.Keywords
This publication has 29 references indexed in Scilit:
- T-cell receptor excision circles in primary immunodeficiencies and other T-cell immune disordersCurrent Opinion in Allergy and Clinical Immunology, 2011
- T-Cell Compartment in Synovial Fluid of Pediatric Patients with JIA Correlates with Disease PhenotypeJournal of Clinical Immunology, 2011
- Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screeningBlood, 2011
- Early vs. delayed diagnosis of severe combined immunodeficiency: A family perspective surveyClinical Immunology, 2011
- Systematic Evidence Review of Newborn Screening and Treatment of Severe Combined ImmunodeficiencyPediatrics, 2010
- Development of a routine newborn screening protocol for severe combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2009
- Thymic Function-Related Markers Within the Thymus and Peripheral Blood: Are They Comparable?Journal of Clinical Immunology, 2006
- Two-tiered universal newborn screening strategy for severe combined immunodeficiencyMolecular Genetics and Metabolism, 2005
- Mutations in genes required for T-cell development:IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE reviewGenetics in Medicine, 2004
- The incidence of primary immunodeficiency syndromes in Israel.2002